KATELYN LAKES: Open Payments
NPI 1841858115 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| ABBVIE INC. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $26 |
| KYOWA KIRIN, INC. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Philips North America LLC | 1 | $16 |
| Legend Biotech USA Inc. | 1 | $16 |
Products named: VENCLEXTA, REBLOZYL, DATROWAY, SCEMBLIX, POTELIGEO, LYNPARZA, KISQALI, ICLUSIG.
Industry payments across IN — which companies pay providers there.
